1,001 hedge funds and large institutions have $36B invested in Biogen in 2023 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 319 increasing their positions, 360 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

less ownership

Funds ownership:

7% less call options, than puts

Call options by funds: $555M | Put options by funds: $599M

5% less funds holding in top 10

Funds holding in top 10: 1918 (-1)

11% less repeat investments, than reductions

Existing positions increased: 319 | Existing positions reduced: 360

Holders
1,001
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
18
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$555M
Puts
$599M
Net Calls
Net Calls Change

Top Buyers

1 +$968M
2 +$253M
3 +$174M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$105M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$103M

Top Sellers

1 -$639M
2 -$273M
3 -$150M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$139M
5
Millennium Management
Millennium Management
New York
-$134M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.56B
2
$4.01B
3
$3.47B
4
$1.96B
5
$1.52B
6
$1.27B
7
$968M
8
$905M
9
$752M
10
$521M
11
$455M
12
$419M
13
$410M
14
$408M
15
$390M
16
$383M
17
$356M
18
$343M
19
$339M
20
$321M
21
$316M
22
$310M
23
$285M
24
$283M
25
$272M